Using breast cancer cell lines, studies showed that Erk5 plays roles in cell proliferation by regulating cyclin D1 and CDKs [36-38], epithelial mesenchymal transition [39], MET/HGF-induced migration [40, 41] and integrin/FAK-mediated metastasis [42]. The gene discussed is MET; the disease is breast cancer.